UBS Group Increases Cardinal Health (NYSE:CAH) Price Target to $122.00

Cardinal Health (NYSE:CAH – Free Report) had its target price raised by UBS Group from $114.00 to $122.00 in a research note released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities analysts also recently issued research reports about the stock. TheStreet downgraded shares of Cardinal Health from […]

Leave a Reply

Your email address will not be published.

Previous post Choice Hotels International (NYSE:CHH) PT Raised to $114.00
Next post Federated Hermes (NYSE:FHI) Price Target Increased to $37.00 by Analysts at Royal Bank of Canada